Background and Objectives
To evaluate the antiallergic effect of low‐level laser irradiation (LLLI) at 650 nm in a mouse model of allergic rhinitis (AR), and to examine the underlying mechanisms.
Study Design/Materials and Methods
BALB/c mice were sensitized with ovalbumin (OVA) and alum and challenged intranasally with OVA. Straight‐ and diffusion‐type LLLI were applied directly into the intranasal cavity of the mice once daily for 10 days (650 nm, 5 mW, 15 min/day) and multiple allergic parameters were evaluated.
Results
LLLI reduced allergic symptoms, such as rubbing and sneezing, and suppressed the serum total immunoglobulin E (IgE), OVA‐specific IgE, and OVA‐specific IgG1 levels. Diffusion‐type LLLI significantly reduced eosinophil infiltration of nasal mucosa and lymph nodes (LNs). LLLI reduced the expression of interleukin‐4 (IL‐4) and IL‐17 in cervical LN and splenocyte culture supernatant, as well as their messenger RNA levels in nasal mucosa. However, the expression of interferonγ (IFN‐γ) and IL‐6 was unaffected by LLLI. The levels of reactive oxygen species (ROS) and nitric oxide (NO) in LN cells and the nasal mucosa, which were increased in the AR group, were reduced by LLLI, suggesting involvement of ROS and NO within their mechanism.
Conclusions
LLLI exerted an antiallergic effect by decreasing local and systemic IL‐4, IL‐17, and IgE levels, as well as eosinophilic infiltration into the nasal mucosa, in a mouse model of AR by modulating ROS and NO levels. Diffusion‐type LLLI exhibited greater efficacy against AR than straight‐type LLLI. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.